VCELNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Vericel Corp
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 30, 2026
$40.37+0.24 (+0.60%)
Close on Oct 19, 2026
- Market cap
- $2.11B
- P/E (TTM)
- 96.1
- Dividend yield
- –
Price history
Daily open, high, low, close and volume
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected. | ||||||
Stock splits
From SEC filings
| Date | Ratio | Effect on per-share figures |
|---|---|---|
| Oct 16, 2013 | 1-for-20 reverse | Earlier per-share figures multiplied by 20 |
| Oct 16, 2013 | 1-for-20 reverse | Earlier per-share figures multiplied by 20 |
| Feb 18, 2010 | 1-for-8 reverse | Earlier per-share figures multiplied by 8 |